# A 58-Year-Old Woman’s Odyssey With Bilateral Nodular Opacities Comes to a Diagnosis

**Authors:** Angeliki Miziou, Romanos Ntiloudis, Panagiotis Kousidis, Anastasia Nikolaidou, Konstantinos I Gourgoulianis, Garifallia Perlepe

PMC · DOI: 10.7759/cureus.102329 · Cureus · 2026-01-26

## TL;DR

A 58-year-old woman with a history of uterine leiomyoma and lung nodules was diagnosed with benign metastasizing leiomyoma, a rare condition that mimics cancer on imaging but is not malignant.

## Contribution

The paper presents a rare case of BML with a 23-year radiologic history, emphasizing the importance of recognizing its non-malignant nature to avoid unnecessary treatment.

## Key findings

- Histopathology confirmed benign smooth muscle tumors in the lungs with no malignancy or atypia.
- FDG-PET imaging showed non-avid masses, complicating the differential diagnosis.
- The patient’s history of uterine leiomyoma and hysterectomy supported the BML diagnosis.

## Abstract

Benign metastasizing leiomyoma (BML) is an uncommon entity in which histologically benign smooth muscle tumors appear at distant sites, most frequently the lungs, in women with a history of uterine leiomyoma treated surgically. Despite its benign pathology, BML often presents radiologically in a pattern that mimics metastatic malignancy, resulting in substantial diagnostic uncertainty. Awareness of this condition is essential for avoiding unnecessary or overly aggressive interventions.

We describe the case of a 58-year-old woman and active smoker with a significant 40-pack-year history who was referred following the incidental discovery of multiple bilateral pulmonary nodules and two enlarging masses during routine coronary CT angiography. Remarkably, retrospective review revealed a 23-year history of slowly progressive pulmonary nodules. The patient was asymptomatic except for a chronic intermittent productive cough. Laboratory testing, including immunologic profiling and tumor markers, was unremarkable, apart from elevated CA-125 levels. Bronchoscopy and transbronchial needle aspiration demonstrated nonspecific fibrosis without evidence of malignancy or infection. Fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging showed multiple photopenic nodules and two non-FDG-avid masses, further complicating the differential diagnosis, which initially included metastatic cancer, granulomatous disease, and primary pulmonary neoplasms. Given the increasing size of the dominant left upper lobe lesion and persistent diagnostic ambiguity, the patient underwent video-assisted thoracoscopic surgery with left upper lobectomy. Histopathological examination revealed intersecting bundles of bland smooth muscle cells without atypia or necrosis, while immunohistochemistry demonstrated strong positivity for SMA, desmin, caldesmon, and estrogen receptors, consistent with pulmonary benign metastasizing leiomyoma. These findings were correlated with the patient’s remote history of hysterectomy for uterine leiomyoma.

This case highlights the diagnostic challenges of BML, particularly when radiologic findings resemble metastatic malignancy over many years. Recognition of its characteristic clinical, imaging, and histologic features is essential to avoid misdiagnosis and overtreatment. Management should be individualized and may include surgical resection, hormonal therapy, or careful surveillance. Long-term follow-up is recommended due to the condition’s variable clinical course and potential for progression.

## Linked entities

- **Proteins:** SMN1 (survival of motor neuron 1, telomeric), LOC101066771 (desmin-like), Cald1 (caldesmon 1)
- **Diseases:** benign metastasizing leiomyoma (MONDO:0022560), uterine leiomyoma (MONDO:0007886)

## Full-text entities

- **Genes:** ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, CALD1 (caldesmon 1) [NCBI Gene 800] {aka CDM, H-CAD, HCAD, L-CAD, LCAD, NAG22}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}, MUC16 (mucin 16, cell surface associated) [NCBI Gene 94025] {aka CA125}, CD34 (CD34 molecule) [NCBI Gene 947], SMN1 (survival of motor neuron 1, telomeric) [NCBI Gene 6606] {aka BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}
- **Diseases:** necrosis (MESH:D009336), smooth muscle tumor (MESH:D018235), mycobacterial or fungal infections (MESH:D009181), rheumatoid nodules (MESH:D012218), infectious granulomatous diseases (MESH:D003141), breast carcinomas (MESH:D001943), pulmonary amyloidosis (MESH:D000686), BML (MESH:D007889), lymphomas (MESH:D008223), amyloid (MESH:C000718787), mediastinal lymphadenopathy (MESH:D008477), sarcoidosis (MESH:D012507), infection (MESH:D007239), mesenchymal tissue neoplasm (MESH:D009380), chest discomfort (MESH:D013898), cough (MESH:D003371), weight loss (MESH:D015431), lung nodules (MESH:D003074), metastases (MESH:D009362), LAM (MESH:D018192), trisomy 12 (MESH:C538299), hypertension (MESH:D006973), hypothyroidism (MESH:D007037), sarcomas (MESH:D012509), fever (MESH:D005334), masses (MESH:C536030), hemorrhage (MESH:D006470), granulomatous disease (MESH:D006105), chest pain (MESH:D002637), Pulmonary lesions (MESH:D008171), Chromosomal abnormalities (MESH:D002869), cancer (MESH:D009369), calcification (MESH:D002114), pulmonary neoplasms (MESH:D008175), dyspnea (MESH:D004417), edema (MESH:D004487), pulmonary nodules (MESH:D055613), uterine leiomyoma (OMIM:150699), melanomas (MESH:D008545), fibrosis (MESH:D005355), inflammatory disorders (MESH:D007249), leiomyosarcoma (MESH:D007890), muscle tumor (MESH:D019042), dyslipidemia (MESH:D050171)
- **Chemicals:** alcohol (MESH:D000438), amlodipine (MESH:D017311), FDG (MESH:D019788), levothyroxine (MESH:D013974), atorvastatin (MESH:D000069059), tamoxifen (MESH:D013629), oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mycobacterium (genus) [taxon 1763], Fungi (kingdom) [taxon 4751]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935280/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935280/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935280/full.md

---
Source: https://tomesphere.com/paper/PMC12935280